Iovance Biotherapeutics (IOVA) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -11.0 | -3.25 | -4.98 | -5.89 | -2.90 | -4.95 | |||
| Changes by years, y/y, % | -57% | -71% | +53% | +18% | -51% | -35.2% | |||
Iovance Biotherapeutics. P/FCF
Iovance Biotherapeutics. P/FCF, changes, %
Iovance Biotherapeutics (IOVA) P/FCF US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| P/FCF | -6.20 | -3.09 | -1.78 | -2.25 | -3.30 | -4.95 | ||
| Changes by years, y/y, % | +14% | -68% | -69% | -71% | -47% | |||
| Changes by quarters, q/q, % | -19% | -50% | -43% | +26% | +47% | |||